ArticleScientific reports2026
Oxidative stress promotes the progression of age-related macular degeneration by up-regulating Spp1 to activate the JAK/STAT signaling pathway.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Age-related macular degeneration (AMD) is the leading cause of visual impairment in elderly people, and due to the unclear specific pathogenesis, eradication treatment cannot be carried out. This study aims to explore the molecular regulatory network and signal transduction mechanism related to the pathogenesis of AMD, with the expectation of providing a theoretical basis for the analysis of the pathological mechanism of AMD and the discovery of potential therapeutic targets. Sodium iodate (NaIO3) was used to induce AMD in mice, and optical coherence tomography (OCT) was used to detect macular degeneration and retinal thickness in their eyes. Differentially expressed mRNAs or proteins were then obtained using differential analysis. Gene set enrichment analysis (GSEA) was used to identify underlying signaling pathways associated with AMD. ARPE-19 cells were induced with H2O2, and cellular oxidative stress was evaluated. Secreted phosphoprotein 1 (SPP1) expression was verified using quantitative real-time PCR (qRT-PCR) and western blot (WB). The relationship between SPP1 expression and signaling pathways was verified using the WB assay. Cell counting kit 8 (CCK-8) was performed to verify the effect of secreted SPP1 expression on the survival of retinal pigment epithelium (RPE) cells. Transcriptomic and proteomic analyses revealed that SPP1 was significantly upregulated in AMD, and a key pathway was obtained: the JAK-STAT signaling pathway. In vitro experiments showed that SPP1 was significantly over-expressed in the AMD group, accompanied by elevated oxidative stress levels. Furthermore, SPP1 knockdown indirectly suppressed JAK-STAT pathway activation by downregulating CD44 expression, thereby contributing to the survival of RPE cells. Overall, this study demonstrates that oxidative stress may promote AMD progression by impairing RPE cell survival through inducing SPP1-mediated CD44 upregulation and JAK-STAT pathway activation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.